Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1-infected patients in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Je Eun | - |
dc.contributor.author | Ahn, Mi Young | - |
dc.contributor.author | Kim, Woo Joo | - |
dc.contributor.author | Kim, Shin-Woo | - |
dc.contributor.author | Lee, Jin Soo | - |
dc.contributor.author | Ku, Nam Su | - |
dc.contributor.author | Kim, Joon Hyung | - |
dc.contributor.author | Kim, Ki-Hyon | - |
dc.contributor.author | Ann, Heawon | - |
dc.contributor.author | Choi, Jun Yong | - |
dc.date.accessioned | 2021-09-02T04:13:35Z | - |
dc.date.available | 2021-09-02T04:13:35Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 0146-6615 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/71971 | - |
dc.description.abstract | ObjectiveThe discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemokine receptor type 5 (CCR5), and C-X-C chemokine receptor type 4 has led to a better understanding of the interaction between HIV envelope and host cells, and development of new therapeutic approaches. The purpose of this study was to estimate the prevalence of CCR5 tropism among HIV-1-infected Koreans and identify the predictors for CCR5 tropism. MethodsWe enrolled 250 HIV-1-infected subjects from four medical centers of three different cities in South Korea between April 2013 and May 2014. Genotypic assay for identifying coreceptor tropism of HIV-1 was performed with HIV RNA or HIV DNA. Nested polymerase chain reaction and population-based sequencing for the V3 region (HXB2 position 6225-7758) of the envelope were performed with HIV RNA or proviral DNA. Proviral DNA was used if the viral load of the subject was below 2000copies/mL. Genotypic tropism was determined by a web-based bioinformatics tool (). ResultsAmong 250 individuals enrolled, only 143 subjects could be analyzed for genotypic tropism assay with HIV RNA or proviral DNA. The prevalence of CCR5 tropism was 69.2% (N=99). We could not identify any significant clinical or epidemiological predictors for CCR5 tropism among enrolled subjects. ConclusionsThe prevalence of CCR5 tropism in HIV-1-infected Korean individuals was 69.2%. Since we cannot predict coreceptor tropism by clinical factors, tropism assay should be performed before treatment with the CCR5 antagonist. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | HIV TROPISM | - |
dc.subject | ANTIRETROVIRAL THERAPY | - |
dc.subject | PROGRESSION | - |
dc.subject | INFECTION | - |
dc.subject | MARAVIROC | - |
dc.subject | REGIMEN | - |
dc.subject | IMPACT | - |
dc.subject | R5 | - |
dc.title | Prevalence of C-C chemokine receptor type 5 tropism among human immunodeficiency virus 1-infected patients in South Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Woo Joo | - |
dc.identifier.doi | 10.1002/jmv.25254 | - |
dc.identifier.scopusid | 2-s2.0-85053876260 | - |
dc.identifier.wosid | 000445620200007 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICAL VIROLOGY, v.90, no.11, pp.1720 - 1723 | - |
dc.relation.isPartOf | JOURNAL OF MEDICAL VIROLOGY | - |
dc.citation.title | JOURNAL OF MEDICAL VIROLOGY | - |
dc.citation.volume | 90 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1720 | - |
dc.citation.endPage | 1723 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Virology | - |
dc.relation.journalWebOfScienceCategory | Virology | - |
dc.subject.keywordPlus | HIV TROPISM | - |
dc.subject.keywordPlus | ANTIRETROVIRAL THERAPY | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | MARAVIROC | - |
dc.subject.keywordPlus | REGIMEN | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | R5 | - |
dc.subject.keywordAuthor | antiretrovirus drug | - |
dc.subject.keywordAuthor | human immunodeficiency virus | - |
dc.subject.keywordAuthor | receptor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.